Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review

References

• Fombonne E. Prevalence of childhood disintegrative disorder. Autism. 2002;6(2):149–157. doi:10.1177/136236130200600200212083281
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association: Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association;2013.
   Google Scholar
• Yates K, Le CA, Szczęsny E (tłumaczenie)Diagnostyka autyzmu. Paediatr Child Heal.2009;19:55–59. doi:10.1016/j.paed.2008.10.010
   Google Scholar
• Duchan E, Patel DR. Epidemiology of autism spectrum disorders. Pediatr Clin North Am. 2012;59(1):27–43. doi:10.1016/j.pcl.2011.10.00322284791
   PubMed Web of Science ®Google Scholar
• Rybakowski F, Białek A, Chojnicka I, et al. Zaburzenia ze spektrum autyzmu - epidemiologia, objawy, współzachorowalnos̈ć i rozpoznawanie. Psychiatr Pol. 2014;48(4):653–665.25314794
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhang HF, Han JS, Han SP. Genes related to oxytocin and arginine-vasopressin pathways: associations with autism spectrum disorders. Neurosci Bull. 2017;33(2):238–246. doi:10.1007/s12264-017-0120-728283809
   PubMed Web of Science ®Google Scholar
• Hovey D, Zettergren A, Jonsson L, et al. Associations between oxytocin-related genes and autistic-like traits. Soc Neurosci. 2014;9(4):378–386. doi:10.1080/17470919.2014.89799524635660
   PubMed Web of Science ®Google Scholar
• Gillberg C, Billstedt E. Autism and asperger syndrome: coexistence with other clinical disorders. Acta Psychiatr Scand. 2000;102(5):321–330. doi:10.1034/j.1600-0447.2000.102005321.x11098802
   PubMed Web of Science ®Google Scholar
• Carter CS. Oxytocin pathways and the evolution of human behavior. Annu Rev Psychol. 2014;65(1):17–39. doi:10.1146/annurev-psych-010213-11511024050183
   PubMed Web of Science ®Google Scholar
• Wigton R, Radua J, Allen P, et al. Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies. J Psychiatry Neurosci. 2015;40(1):1–22. doi:10.1503/jpn.130289
   Web of Science ®Google Scholar
• Miller M, Bales KL, Taylor SL, et al. Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms. Autism Res. 2013;6(2):91–102. doi:10.1002/aur.127023413037
   PubMed Web of Science ®Google Scholar
• Taurines R, Schwenck C, Lyttwin B, et al. Oxytocin plasma concentrations in children and adolescents with autism spectrum disorder: correlation with autistic symptomatology. Atten Deficit Hyperact Disord. 2014;6(3):231–239. doi:10.1007/s12402-014-0145-y
   PubMedGoogle Scholar
• Wójciak P, Remlinger-Molenda A, Rybakowski J. Rolaoksytocyny i wazopresyny w czynności ośrodkowego ułkadu nerwowego i w zaburzeniach psychicznych. Psychiatr Pol. 2012;46(6):1043–1052.23479945
   PubMed Web of Science ®Google Scholar
• Schmeisser MJ, Boeckers TM, editors. Translational Anatomy and Cell Biology of Autism Spectrum Disorder New York: Springer International Publishing; 2017.
   Google Scholar
• Althaus M, Groen Y, Wijers AA, et al. Do blood plasma levels of oxytocin moderate the effect of nasally administered oxytocin on social orienting in high-functioning male adults with autism spectrum disorder? Psychopharmacology (Berl). 2016;233:2737–2751. doi:10.1007/s00213-016-4339-127256356
   PubMed Web of Science ®Google Scholar
• Jacobson JD, Ellerbeck KA, Kelly KA, et al. Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism. Psychoneuroendocrinology. 2014;40(1):159–169. doi:10.1016/j.psyneuen.2013.11.01424485488
   PubMed Web of Science ®Google Scholar
• Zhang HF, Dai YC, Wu J, et al. Plasma oxytocin and arginine-vasopressin levels in children with autism spectrum disorder in china: associations with symptoms. Neurosci Bull. 2016;32(5):423–432. doi:10.1007/s12264-016-0046-527342432
   PubMed Web of Science ®Google Scholar
• Preti A, Melis M, Siddi S, Vellante M, Doneddu G, Fadda R. Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials. J Child Adolesc Psychopharmacol 2014;24(2):54–68. doi:10.1089/cap.2013.004
   Google Scholar
• Al-Ayadhi LY. Altered oxytocin and vasopressin levels in autistic children in Central Saudi Arabia. Neurosciences. 2005;10(1):47–50.22473184
   PubMedGoogle Scholar
• Boso M, Emanuele E, Politi P, et al. Reduced plasma apelin levels in patients with autistic spectrum disorder. Arch Med Res. 2007;38(1):70–74. doi:10.1016/j.arcmed.2006.08.00317174726
   PubMed Web of Science ®Google Scholar
• Carson DS, Garner JP, Hyde SA, et al. Arginine vasopressin is a blood-based biomarker of social functioning in children with autism. PLoS ONE 2015:1–14. doi:10.1371/journal.pone.0132224
   Google Scholar
• Kurth F, Narr KL, Woods RP, et al. Diminished gray matter within the hypothalamus in autism disorder: a potential link to hormonal effects? Biol Psychiatry. 2011;70(3):278–282. doi:10.1016/j.biopsych.2011.03.02621531390
   PubMed Web of Science ®Google Scholar
• Shou X, Xu X, Liu XZY. A volumetric and functional connectivity MRI study of brain arginine-vasopressin pathways in autistic children. Neurosci Bull. 2017;33(2):130–142. doi:10.1007/s12264-017-0109-228258508
   PubMed Web of Science ®Google Scholar
• Francis SM, Sagarb A, Levin-Decaninia T, Liuc W, Carterd CS, Jacob S. Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders. Brain Research. 2015;199–218. doi:10.1016/j.brainres.2014.01.021.Oxytocin
   Google Scholar
• Carter CS. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders? Behav Brain Res. 2007;176(1):170–186. doi:10.1016/j.bbr.2006.08.02517000015
   PubMed Web of Science ®Google Scholar
• Rynkiewicz A, Janas-Kozik M, Słopień A. Girls and women with autism. Psychiatr Pol. 2018;2:1–16. doi:10.12740/PP/OnlineFirst/95098
   Web of Science ®Google Scholar
• Loomes R, Hull L, Mandy WPL. What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(6):466–474. doi:10.1016/j.jaac.2017.03.01328545751
   PubMed Web of Science ®Google Scholar
• Aita C, Mizoguchi Y, Yamamoto M, et al. Oxytocin levels and sex differences in autism spectrum disorder with severe intellectual disabilities. Psychiatry Res. 2019;273:67–74. doi:10.1016/j.psychres.2018.12.13930640053
   PubMed Web of Science ®Google Scholar
• Harony H, Wagner S. The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in. Neurosignals 2010;82–97. doi:10.1159/000321035
   Google Scholar
• Oztan O, Jackson LP, Libove RA, et al. Biomarker discovery for disease status and symptom severity in children with autism. Psychoneuroendocrinology. 2018;89:39–45. doi:10.1016/j.psyneuen.2017.12.02229309996
   PubMed Web of Science ®Google Scholar
• Modahl C, Green LA, Fein D, et al. Plasma oxytocin levels in autistic children. Biol Psychiatry. 1998;43(4):270–277. doi:10.1016/S0006-3223(97)00439-39513736
   PubMed Web of Science ®Google Scholar
• Alabdali A, Al-ayadhi L, El-ansary A. Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J Neuroinflammation 2014;11:4. doi:10.1186/1742-2094-11-4
   Google Scholar
• Green L, Fein D, Modahl C, Feinstein C, Waterhouse L, Morris M. Oxytocin and autistic disorder: alterations in peptide forms. Biological Psychiatry. 2001;3223(1985):609–613.
   Google Scholar
• Abdulamir HA, Abdul-Rasheed OF, Abdulghani EA. Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children. Saudi Med J. 2016;37(1):29–36. doi:10.15537/smj.2016.1.1318326739971
   PubMed Web of Science ®Google Scholar